Checkmate 9er News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Checkmate 9er. Real-time updates on events, politics, business and more.

Advanced RCC: Safety and Efficacy of IO/TKI Combination Therapies

October 11, 2023

Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.

Advanced Kidney Cancer Treatment Landscape Kidney Cancer Renal Cell Carcinoma Kidney Cancer Studies Kidney Cancer Trials Clear Trial

Source: curetoday.com

Dr Tsao on the Role of Nivolumab Plus Cabozantinib in Advanced RCC

May 25, 2023

Che-Kai Tsao, MD, discusses key updates from the phase 3 CheckMate 9ER trial, and how these data clarify the role of nivolumab plus cabozantinib as a new standard of care in renal cell carcinoma.

Che Kai Tsao Icahn School Of Medicine At Mount Sinai Icahn School Mount Sinai Cancers Symposium Genitourinary Cancers

Source: onclive.com

Front Line Trials in Advanced RCC

March 24, 2023

Renal cell carcinoma experts discuss clinical trials, evaluating immunotherapies and tyrosine kinase inhibitors in the front line setting of advanced RCC.

Benjamin Garmezy Pedro Barata Renal Cell Carcinoma Clear Trial Checkmate 9er Keynote 426

Source: onclive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Checkmate 9er News Today

Advanced RCC: Safety and Efficacy of IO/TKI Combination Therapies

Dr Tsao on the Role of Nivolumab Plus Cabozantinib in Advanced RCC

Front Line Trials in Advanced RCC

Explore More Categories